Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sulfacetamide sodium 10% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfacetamide sodium 10% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfacetamide sodium 150 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenylephrine hydrochloride + sulfacetamide sodium 1.25mg/150mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate + sulfacetamide sodium 0.2%wv/10%wv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely prednisolone acetate 2 milligram/1 gram and sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate + sulfacetamide sodium 0.25%wv/10%wv suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate + sulfacetamide sodium 5mg/100mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate + sulfacetamide sodium 5mg/100mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenylephrine hydrochloride + sulfacetamide sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfacetamide 10% eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate + sulfacetamide sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prednisolone acetate + sulfacetamide sodium 0.5%ww/10%ww ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfacetamide sulfate + sulfur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has precise active ingredient |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfacetamide sodium 150 mg/mL eye solution |
Has precise active ingredient |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfacetamide sodium 150 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Has basis of strength substance (attribute) |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Has precise active ingredient |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluorometholone + sulfacetamide sodium 0.1%wv/10%wv suspension |
Has precise active ingredient |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluorometholone + sulfacetamide sodium 0.1%wv/10%wv suspension |
Has basis of strength substance (attribute) |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has precise active ingredient |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfacetamide sodium 300 mg/mL eye solution |
Has precise active ingredient |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfacetamide sodium 300 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfacetamide sodium 100 mg/g eye ointment |
Has basis of strength substance (attribute) |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfacetamide sodium 100 mg/g eye ointment |
Has precise active ingredient |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfacetamide sodium 200 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfacetamide sodium 200 mg/mL eye solution |
Has precise active ingredient |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfacetamide sodium 60 mg/g eye ointment |
Has basis of strength substance (attribute) |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfacetamide sodium 60 mg/g eye ointment |
Has precise active ingredient |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfacetamide sodium 25 milligram/1 gram conventional release eye ointment (clinical drug) |
Has precise active ingredient |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfacetamide sodium 25 milligram/1 gram conventional release eye ointment (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream |
Has basis of strength substance (attribute) |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream |
Has precise active ingredient |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone acetate 2 milligram/1 gram and sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely prednisolone acetate 2 milligram/1 gram and sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug) |
Has precise active ingredient |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has basis of strength substance (attribute) |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has precise active ingredient |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder |
Has precise active ingredient |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder |
Has basis of strength substance (attribute) |
True |
Sulfacetamide sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |